12,167 followers
RT @FrontOncology: New research: Long-term complete response with third-line PARP inhibitor after immunotherapy in a patient with triple-ne…
RT @FrontOncology: New research: Long-term complete response with third-line PARP inhibitor after immunotherapy in a patient with triple-ne…
New research: Long-term complete response with third-line PARP inhibitor after immunotherapy in a patient with triple-negative breast cancer: a case report: While standard treatment has shown efficacy in patients with breast cancer gene (BRCA)… #oncology h
https://t.co/wxrzLVt04E Long-term complete response with third-line PARP inhibitor after immunotherapy in a patient with triple negative breast cancer: A case report #TNBC